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Abstract
Chiari disease (or malformation) is in general a congenital condition characterized by an anatomic
defect of the base of the skull, in which the cerebellum and brain stem herniate through the
foramen magnum into the cervical spinal canal. The onset of Chiari syndrome symptoms usually
occurs in the second or third decade (age 25 to 45 years). Symptoms may vary between periods
of exacerbation and remission. The diagnosis of Chiari type I malformation in patients with or
without symptoms is established with neuroimaging techniques. The most effective therapy for
patients with Chiari type I malformation/syringomyelia is surgical decompression of the foramen
magnum, however there are non-surgical therapy to relieve neurophatic pain: either
pharmacological and non-pharmacological. Pharmacological therapy use drugs that act on different
components of pain. Non-pharmacological therapies are primarly based on spinal or peripheral
electrical stimulation.
It is important to determine the needs of the patients in terms of health-care, social, educational,
occupational, and relationship issues, in addition to those derived from information aspects,
particularly at onset of symptoms.
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to approach, monitor, follow-up, and treat the condition.
It is necessary that the physicians involved in the care of people with this condition
comprehensively approach the management and follow-up of the patients, and that they organize
interdisciplinary teams including all the professionals that can help to increase the quality of life of
patients.
Background
For several decades, the eponyms Arnold and Chiari have
been used as synonyms to define conditions with ectopia
of the cerebellar tonsils below the level of the posterior
edge of the foramen magnum. The first case was described
by Cleland in 1883. The most detailed original descrip-
tion, however, was made by Chiari in 1891. In the mid-
1970s, the term Chiari was again used to name the syn-
drome.
Chiari syndrome is a developmental malformation of the
occipital mesodermal somites that can be associated to
syringomyelia and hydrocephalus. The most extreme
form consists of the herniation of structures of the lower
cerebellum, the cerebellar tonsils, and brain stem through
the foramen magnum, in such a way that parts of the
brain enter the spinal canal, thickening and compressing
it. Symptoms typically appear during adolescence or
adulthood, and are not usually accompanied by hydro-
cephalus. In general, patients complain of recurrent head-
ache, cervical pain, and progressive spasticity of the lower
limbs.
Among the many malformations of the craniocervical
junction, Chiari type I syndrome and syringomyelia are
noteworthy because of their prevalence and the serious-
ness of their symptom.
The word syringomyelia means reed- or flute-like spinal
cord. The disease affects both genders, although with
slight predominance in women, and all races. Although
most authors consider the average at presentation approx-
imately 35 years [1-5], symptoms onset can occur at any
age, from 1 year [6,7] to older than 60 and are highly
uncommon in people older than 65 years [8]. In most
cases syringomyelia is due to craniocervical malforma-
tions, mainly Chiari malformation and basilar impres-
sion, so all the problems due to those conditions added to
those of syringomyelia, can severely affect the patient's
quality of life if adequate and timely measures are not
taken.
There are two types of therapies to treat these malforma-
tions: surgical therapy, that should be considered for
symptomatic patients and which main goal is the decom-
pression of the foramen magnum; and non-surgical ther-
apy, used to relieve the symptoms caused by neuropathic
pain.
Although malformations of the craniocervical junction
are considered rare diseases (RDs) due to their low inci-
dence, the increasingly frequent use of neuroimaging
techniques in clinical protocols has led to such a large
increase in the diagnosis of tonsil herniations that there is
discussion in the medical literature about whether the
prevalence figures known for these diseases should be
revised. On the other hand, it is important to develop a
consensus regarding the management and the therapeutic
approach of these malformations, particularly, consider-
ing that in many cases they remain asymptomatic for
years.
A classification of the Chiari malformation and related
issues about the disease, such as diagnosis and treatment
is discussed below, as well as their social and health con-
cernings.
Classification
The classification of Chiari malformation recognizes five
subtypes:
Chiari type 0 malformation: characterized by an alteration
in Cerebro Spinal Fluid (CSF) hydrodynamics at the level
of the foramen magnum. Patients with this subtype have
syringomyelia either without tonsil herniation or with
only mild tonsil herniation-associated findings.
Chiari type I malformation: caudal herniation of the cere-
bellar tonsils exceeding 5 mm below the foramen mag-
num. This malformation is typically associated with
hydrosyringomyelia. It is not usually accompanied by
descent of the brain stem or IV ventricle, nor associated
with the presence of hydrocephalus.
Chiari type II malformation: caudal herniation of the cere-
bellar vermis, brain stem, and IV ventricle through the
foramen magnum. It is associated with myelomenin-
gocele, hydrocephalus, and, less frequently, hydrosyringo-
myelia. Other types of intracranial defects (hypoplastic
tentorium cerebelli, cranial lacunae, anomalies of the Syl-
vius aqueduct) may exist.Page 2 of 11
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locoele, with some of the intracranial defects associated
with Chiari II malformation.
Chiari type IV malformation: cerebellar aplasia or hypopla-
sia, associated with aplasia of the tentorium cerebelli.
Chiari type I malformation is undoubtedly the most fre-
quent subtype. It can coexist with other defects, which are
classified according the involved area:
Spinal cord: The most frequent defect associated to Chiari
I is syringomyelia. It is agreed that 40-75% of Chiari type
I malformations have associated syringomyelia. In con-
trast, almost 90% of syringomyelias are associated with
Chiari malformation. Syringomyelia is a chronic spinal
cord defect in which a tubular cavity, or central cavitation,
is present in several spinal cord segments  (Figure 1).
The cervical region is the most frequently involved, but
the dilation may extend cranially to the brain stem or cau-
dally to the thoracic or lumbar segments. Four types of
syringomyelia exist:
Type I: syringomyelia with obstruction of the foramen
magnum and dilation of the central spinal canal: A) Asso-
ciated to Chiari type I malformation. B) Associated with
other obstructive lesions of the foramen magnum
Type II: syringomyelia without obstruction of the foramen
magnum, or idiopathic.
Type III: syringomyelia with other diseases of the spinal
cord. A) Spinal cord tumours (usually intraspinal) B)
Traumatic myelopathy C) Spinal arachnoiditis and pachy-
meningitis D) Myelomalacia due to compression of the
spinal cord (tumour, spondylosis)
Type IV: Pure hydromyelia, usually associated to hydro-
cephalus.
Bone malformations of the craniocervical junction occur
in about 50% of  the patients with Chiari type I malforma-
tion, although the frequency ranges from 45 to 60%,
depending on the series.
Posterior fossa volume anomalies are highly significant
due to their pathogenic implications. It has been observed
that the posterior fossa is narrower and smaller in patients
with Chiari malformation than in the general population.
Skull defects sometimes are underdiagnosed if appropri-
ate diagnostic tools are not used. Empty sella turcica,
platybasia (flattening of the skull base), basilar impres-
sion (elevation of the floor of the posterior fossa with
inward displacement of the dens within the occipital
foramen), third occipital condyle, and vestiges of the
proatlas usually cause anterior compression of the bulbos-
pinal junction, contributing, together with the posterior
compression that Chiari malformation causes, to the
reduction of the space for the neuroaxis at the level of the
bulbospinal junction.
Spine defects: Klippel-Feil anomaly, or fusion of the atlas
to the occipital. Dens retroflexion and scoliosis may also
be present. Scoliosis has been found in 50-70% of Chiari
type II malformations, whereas the association seems to
be less frequent in type I malformations, depending on
the series. Scoliosis is almost always associated to syringo-
myelia and has a left curvature, unlike idiopathic scolio-
sis, which usually is a dextroscoliosis. In cases with
syringomyelia, weakness of the spinal axial musculature is
due to a progressive disorder of the motor neuron, which
results in denervation of the paravertebral muscles.
Ventricles and cisterns: Hydrocephalus only occurs in 3-
10% of patients with Chiari type I malformation. In con-
trast, practically always occur in Chiari type II malforma-
tion.
Meninges: Thinning of the meninges occurs at the level of
the foramen magnum. Several bands of dura mater con-
stricting the foramen magnum and posterior arch of the
atlas are often present. In surgical series, arachnoiditis
caused by repeated rubbing of the abnormally herniated
cerebellar tonsils against the leptomeninge and dura
mater in the foramen magnum has been reported. Arach-
noiditis has been confirmed in postoperative histopathol-
ogy studies and it is believed to increase as the herniation
evolves in time.
Brain: In Chiari I malformations, no associated cerebral
anomalies exist. The only defect sometimes observed is
Patient with Chiari I malformation (left) and cervical syringo-myelia (rig t)Figure 1
Patient with Chiari I malformation (left) and cervical syringo-
myelia (right)Page 3 of 11
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herniated cerebellar tonsils. These findings do not have
clinical implications.
There is no universally accepted theory explaining the
Chiari malformation and its associated anomalies. Even
acquired forms of cerebellar tonsil herniation are recog-
nised. Chiari I and II malformation tend to be more fre-
quent in women and, in some subtypes of Chiari
malformation, a genetic factor is beginning to be dis-
cussed. Two findings support the existence of a genetic fac-
tor: the familial association observed and the coexistence
with genetic anomalies (Klippel-Feil or achondroplasia).
Families with several members affected have been
reported and Milhorat et al [9] found that 12% of patients
in their series have a close family member with Chiari type
I malformation or syringomyelia. Despite all these cases,
no definitive conclusion can be drawn regarding the sus-
pected existence of a genetic factor and the familiar asso-
ciation for this condition.
In the Chiari I-syringomyelia complex, various patho-
genic hypotheses are currently postulated, although the
most accepted refer to a mechanical factor (excessively
small posterior fossa) and an embryonic developmental
anomaly [10-15].
Clinical manifestations
The onset of Chiari syndrome symptoms usually occurs in
the second or third decade (age 25 to 45 years), although
it is commonly earlier in patients with syringomyelia.
Symptoms generally have an insidious onset and a pro-
gressive course. There is high clinical variability among
patients, ranging from asymptomatic patients, patients
with non-specific clinical manifestations, to patients with
severe neurologic deficits.
Symptoms
Symptoms may vary between periods of exacerbation and
remission. Suboccipital headache is the most frequent
symptom in these patients. The headache is located in the
occipital and is of oppressive nature, increasing with Val-
salva manoeuvres (such as coughing, sneezing, or bowel
movement). The headache can also have non-specific fea-
tures or a tensional profile.
Neck pain is frequent and characterized by the absence of
radicular distribution. It is associated to continuous,
burning, deep-seated discomfort in the shoulders, nape,
chest, and upper limbs. Neck pain usually increases with
Valsalva manoeuvres.
Vertigo can occur, particularly positional vertigo, or trig-
gered by head movements. Other otological symptoms
present in these patients are tinnitus and aural fullness.
Occasionally, mild neurosensorial hearing loss, with
peripheral vestibulopathy is found in otological evalua-
tions
Other frequent symptoms are ocular, often with unre-
markable neuro-ophthalmologic examination. The most
frequent ocular symptoms are: retro-orbital headache,
diplopia, photopsia, blurred vision, and photophobia.
In very severe cases in which compression of the spinal
cord or medulla oblongata occurs, symptoms of involve-
ment of the motor or sensory pathways, or lower cranial
nerves exist.
Breathing-related sleep disorders were frequently reported
in patients with craniocervical junction malformations.
Chiari type I malformation should be considered in the
differential diagnosis of central apnoeas in infants, espe-
cially when they are associated with other neurological
sign or symptom. Some authors considered the presence
of sleep disorders as an earlier marker of progressive brain
stem dysfunction. [16-18]
Physical signs
Phenotypically, up to 25% of patients may have a short,
or bull-like neck. In cases associated to syringomyelia, lev-
oscoliosis may be present. In these patients, the involve-
ment of various nervous structures result in mixed
physical signs:
First motor neuron: generalised hypereflexia, spasticity, and
Babinski reflex, mostly in the lower limbs.
Second motor neuron: atrophy, weakness, fasciculations,
and areflexia, mostly in the upper limbs.
Sensory system: central cord syndrome typical of syringo-
myelia.
Cerebellum: nystagmus, ataxia, and dysmetria.
Lower cranial nerves: affected in 15-25% of cases. The fol-
lowing findings may exist: vocal cord paralysis, soft palate
weakness, lingual atrophy, cricopharyngeal achalasia,
facial hypoaesthesia, and absent gag reflex (the most fre-
quent physical sign indicating involvement of the lower
cranial nerves).
Diagnosis
The delay from the onset of the disease to the diagnosis of
any craneocervical junction malformation, before 1985
was significantly longer than after 1985 when magnetic
resonance imaging became widely available in clinical
practice. That period of time usually was shorther in the
pediatric group. [19]Page 4 of 11
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with or without symptoms is established with neuroimag-
ing techniques; the preferred technique is magnetic reso-
nance imaging (MRI) [20]. MRI can also be used to study
the volume of the posterior fossa and CSF flow dynamics.
The diagnosis of syringomyelia should be made by MRI of
the complete spine (cervical, dorsal, and lumbar). Plain
radiography and Computed Axial Tomography (CAT) are
used to study bone anomalies. Cranial CAT is also useful
for monitoring hydrocephalus.
Therapy
Surgical therapy
Asymptomatic patients who are diagnosed of Chiari type
I malformation without syringomyelia should not be con-
sidered as candidates for surgery. In asymptomatic Chiari
type I malformation with syringomyelia, the opinion of
neurosurgeons varies. In symptomatic patients, surgical
treatment should be considered.
Approximately 10% of patients with Chiari type I malfor-
mation have hydrocephalus. Various techniques are used
to treat this malformation, but they all involve decom-
pression at the foramen magnum.
As in all surgical procedures, decompression of the
foramen magnum in Chiari malformation is not free from
complications. Most of them involve CSF disorders,
which are usually present in about 10% of patients. These
include CSF fistula, meningitis, hydrocephalus, or the
progression of syringomyelia. Postoperative relief of pre-
operative pathologies was experienced in 83% of patients.
Of the most common presenting symptoms, headache/
neck pain and scoliosis, 12 and 17%, respectively, were
not alleviated postoperatively. However, the mortality
rate, which is usually due to respiratory arrest in the
immediate postoperative period or a serious sequela,
should be less than 2%. [21,22]
Most patients experience an improved quality of life after
surgery. The symptoms that improve most are mainly
headache and neck pain, followed by symptoms attribut-
able to direct compression of the cerebellum or brain stem
(e.g., dysphagia, ataxia, nystagmus, and diplopia). In con-
trast, the symptoms attributable to syringomyelia (pain,
scoliosis, and loss of sensitivity) improve less.
If syringomyelia persists, inadequate decompression of
the craniocervical junction should be considered. Syringo-
myelia can reappear in up to 10-20% of patients, due to
either inadequate decompression or excessive scar tissue
formation, impairing CSF flow.
In post-traumatic syringomyelia (Figure 2), some authors
[23,24] prefer to restore the canal, which avoids CSF
blockade, and empty the cyst or leave a drainage tube in
the subarachnoid space. Other authors support conserva-
tive treatment [25]. In cases of syringomyelic cysts associ-
ated to tumours, cyst reduction is generally achieved by
excising the tumour [26,27].
Non-surgical therapy
Analgesia
Neuropathic pain is caused by the lesion of junctional
structures between the cerebral base and the cerebellum,
and the cervical spinal cord. When a nervous system
lesion occurs, different symptoms appear, some are due to
loss of function when damage is severe and there is total
disruption of nerve conduction; other symptoms are due
to irritation (Table 1)
Physical findings typical of neuropathic pain can be
found, particularly:
Allodynia: a painful response to a non-painful stimulus,
such as, brushing the skin with a cotton wad or sponge.
Hyperalgesia: an excessively painful response to a mildly
painful stimulus, such as a slight prick.
Pain therapy in Chiari/syringomyelia is problematic, as in
any disease with low incidence, in which there is little sci-
entific evidence. Given the high variability in intensity,
severity, and location of symptoms, each patient must
receive individualized treatment. Globally, there are two
types of therapy: pharmacological and non-pharmacolog-
ical.
Syringomyelia as a result of fracture of the thoracic spine.Figure 2
Syringomyelia as a result of fracture of the thoracic spine.Page 5 of 11
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Neuropathic pain should be managed with a multifacto-
rial approach using drugs that act on different compo-
nents of pain, including disturbed neuronal activity
(anticonvulsants [28-32] and local anaesthetics [33]),
potentiation of descending inhibitory pathways (antide-
pressants [34]), or centres involved in the development
and conduction of nociceptive responses (analgesics [35-
37]). Some of these drugs, their mode of action and side
effects are described in Table 2.
Neuropathic pain has traditionally been considered resist-
ant to analgesics, specifically opiates, but it is now admit-
ted that there is some response to these molecules, but less
satisfactory than in nociceptive pain. Although the use of
most of these drugs is backed by scientific evidence
obtained in the treatment of other forms of neuropathic
pain, evidence of their effect against the pain produced by
Chiari syndrome or syringomyelia is limited due to the
low incidence of these conditions and the lack of studies
assessing non-surgical treatment for these patients. Some
studies suggest that the use of drug combinations, such as
weak opiates with anticonvulsants, can be more effective
in neuropathic pain and require lower doses.
Spinal infusion of medications has been used for years,
but there is little evidence of its efficacy in neuropathic
pain and none in Chiari syndrome. Spinal infusion sys-
tems comprise an implantable pump system for control-
led drug administration, and a catheter through which the
medication is directly infused into the cerebrospinal fluid
bathing the spinal cord. Implantation of both elements
allows prolonged therapy without complications. Drugs
used most often with this system include morphine, bupi-
vacaine, clonidine [38], and baclofen [39].
Non-pharmacological pain management
While little evidence is available to support pharmacolog-
ical therapy for pain, there is no evidence at all on the
effect of non-pharmacological therapies. Therapies that
could benefit these patients are reserved for use when all
Table 1: Symptoms due to loss of funtion, when damage is severe 
and there is total disruption of nerve conduction. Symptoms due 
to irritation, when the lesion is less severe or nerve conduction is 
not totally disrupted.
Symptoms due to loss funtion Symptoms due to irritation
Motor symptoms
Paresis
Paralysis
Myoclonia
Fasciculations
Spasticity
Sensory symptoms
Hypoaesthesia
Hypoalgesia
Anosmia
Amaurosis
Deafness
Vasodilations
Hypo/anhydrosis
Loss of pilorection
Paraesthesia
Dysaesthesia
Allodynia
Hyperalgesia
Pain
Photopsia
Tinnitus
Vasoconstriction
Hyperhyrosis
Pilorection
Autonomic symptoms
Table 2: Drugs used to manage neurophatic pain and their mode of action.
Type Mode of action Drug Side effect
Anticonvulsants Inhibits opening neuronal voltage –dependent 
channels (calcium channels, sodium channel ) 
andGABA receptor. 
Carbamazepine 
Gabapentin
Pregabalin
Topiramate
Hepatotoxicity, drowsiness, fatigue, ataxia, 
vertigo, gastrointestinal discomfort headache, 
blurred vision.
Antidepressants Inhibits the re-uptake of the neurotransmitters 
norepinephrine and serotonin by neurons. 
Amitriptyline
Duloxetine
Venlafaxine
Mouth dryness, intense sedation, fatigue, 
diminished libido, weight loss, nausea, 
insomnia, headache.
Local anaesthetics Act mainly by inhibiting sodium influx through 
sodium-specific ion channels in the neuronal cell 
membrane.
Lidocaine
Mexiletine
Dizzine, arrhythmia.
Analgesics Act through specific receptors, particularly μ 
receptors distributed throughout the central and 
peripheral nervous system blocking them.
Tramadol
Dextropropoxyphene
Buprenorphine
Morphine
Oxycodone
Fentanyl
Methadone
Nausea, vomiting, sweating, dizzines, mouth 
dryness, sedation, vertigo.Page 6 of 11
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apies are primarly based on spinal or peripheral electrical
stimulation.
When the symptoms of neuropathic pain are localized in
a specific territory, such as one or both upper or lower
limbs, electrical stimulation [40] is a potential option.
Although spinal stimulation has demonstrated its efficacy
in certain types of neuropathic pain, this is not the case for
central pain, and there is no evidence available in patients
with Chiari syndrome. However, since this therapy is free
of major side effects, and any side effect that could occur
is reversible, it is an option to be considered before using
more questionable therapeutic approaches. Peripheral
stimulation has been used recently to treat certain condi-
tions. For example, headache refractory to pharmacologic
therapy has been treated with electric stimulation of the
occipital nerves. There is little evidence available on the
efficacy of this therapy because the technique has been
very recently developed, but it could be a therapeutic
option for headache in patients with Chiari syndrome if
no other treatment has been effective.
Rehabilitation
Rehabilitation is a medical specialty that receives patients
referred from both primary care and specialized care.
Patients with Chiari malformation are often referred by a
general practitioner with a diagnosis of chronic persistent
neck pain, only to have the rehabilitation, specialist dis-
cover the malformation after obtaining a magnetic reso-
nance imaging. Next, rehabilitation therapy is prescribed,
including: medical, physical, and occupational therapy.
Medical therapy includes the use of analgesics, anti-
inflammatory agents, and myorelaxants to reduce pain
symptoms, which can have a mechanical rhythm or be of
neuropathic type.
Physical therapy is also designed to relieve pain and to
preserve the range of motion in the cervical spine joints
and the shoulders.
The goal of occupational therapy is to give recommenda-
tions to the patient for the optimization of articular move-
ments in order to reduce overloading of the upper limbs
and neck, allowing the patients to continue their daily life
activities (DLA) and work activities.
Physical therapy
The role of physical therapy in the multidisciplinary proc-
ess of rehabilitation is the management of the patient's
physical.
Taking into account the most frequent manifestations, the
goals of physical therapy interventions include reduction
of pain and spasticity, tone normalization, improvement
of muscular activity and articular range of movement, bal-
ance and upright reactions re-education, and, facilitation
of cervical spine, pectoral girdle, upper limbs, pelvic gir-
dle, and lower limbs movements. There are different ther-
apeutic options, physical therapy methods and
techniques used to alleviate the pain: superficial and deep
thermotherapy, electrotherapy, and massotherapy.
Methods that merit comment because alleviate motor dis-
orders are: general kinesitherapy, postural treatment, spe-
cific kinesitherapy (proprioceptive neuromuscular
facilitation [41], inhibition-facilitation of patterns of
movement [42-44], cognitive therapeutic exercise [45]),
balance and upright reactions re-education techniques
(re-education of the cerebellar syndrome), gait re-educa-
tion techniques, orofacial function, hydrotherapy, and
balneotherapy.
The objective of physical therapy is to preserve and/or
recover the patient's autonomy, reduce dependence, and
improve quality of life. The patient should also consider
certain behaviors and attitudes, some to follow and others
to avoid.
Speech therapy
Craniocervical malformations can cause speech disorders
as a result of paralysis, weakness, or incoordination of the
speech musculature, with motor and functional disorders
that affect phonation, resonance, articulation, and pros-
ody [46].
Speech, swallowing, phonation, and respiration are func-
tions that may be disturbed in people with Chiari syn-
drome and syringomyelia. They are part of the
rehabilitation realm of the speech therapist. In children,
in addition to the functional disorders mentioned above,
language development and learning may be affected.
Speech therapy has two types of intervention: preventive
and palliative.
When a deviation from normal function is detected, even
if it is mild, the patient and family members must be
informed about the difficulties that may occur as the con-
dition progresses. Reinforcement of swallowing, respira-
tion, vocal tension and reading skills is important to
preserve such functions. If no rehabilitation is initiated
one problem can lead to another. For example, buccofa-
cial motricity disorders can lead not only to swallowing
disorders, but also to chewing and phonation abnormali-
ties. Once the lesion is established, speech therapist inter-
ventions are palliative, targeting the areas where
dysfunction is identified.Page 7 of 11
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Craniosacral osteopathy is another manual therapeutic
resource in the management of Chiari syndrome; its pur-
pose is to minimize symptoms and to improve the quality
of life of the patient. In its minimal expression, the thera-
peutic approach has two basic principles; integrating ver-
tebral biomechanics and normalizing tissular
biodynamics, which as a whole, form an integrated func-
tional unit whose components influence and interact with
each other in the craniosacral system.
The anatomical and mechanical disturbances characteris-
tic of Chiari syndrome in the craniocervical junction have
a compressive mechanical effect on the dural membrane
in its passage through the foramen magnum. They con-
tribute to a modification in the hydrodynamic values of
the Intracranial Pressure (ICP) and explain the broad
array of symptoms associated to Chiari syndrome, which
are related with the sensory organs, sensitivity, stability,
balance, and motricity.
The goals for craniosacral osteopathy are to eliminate the
restrictions that oppose or limit normal CSF flow, in order
to maintain constant hydrodynamic values, allowing an
efficient supply to tissues and nerves to conserve homeo-
static integrity.
Interventions on the biomechanics of the craniosacral axis
and actions on connective tissue restrictions and the extra-
cellular matrix, where all the enzymatic metabolic and
stimulus transmission processes take place [47], are the
therapeutic bases of craniosacral osteopathy in Chiari syn-
drome.
Psychological issues
The human being is conceived as a global being integrated
by biological and psychological components in constant
interaction with their environment. In this sense, chronic
conditions, like Chiari syndrome and syringomyelia,
involve a situation of change in which all the components
of a person's health are implicated.
The World Health Organisation (WHO) defines health as
“a state of complete physical, mental and social well-
being, and not just the absence of disease or illness.” The
introduction of the social factor as an element that config-
ures the state of well-being, together with the physical and
mental factors, means that psychosocial care is needed to
cope with a health problem like Chiari syndrome and
syringomyelia.
Therefore, a combined medical and psychological inter-
vention is required for each patient, with the major objec-
tives of reducing the psychosocial impact of the disease
and improving the patient’s quality of life. In this context,
psychotherapy is a therapeutic element that should be
considered mandatory in the comprehensive manage-
ment of patients with Chiari syndrome and syringomye-
lia. From this perspective, there are therapeutic options
that reduce the psychosocial impact caused by the disease
and improve the patient’s quality of life.
Social and health ssues
The management of craniocervical malformations should
begin with a correct and adequate diagnostic orientation
and care of the patients, with a complete medical history
and physical examination. Given the variability of their
clinical expression, these malformations usually are not
diagnosed in primary care centres, which are the natural
gateway to the health-care system. They are identified pri-
marily in specialized care or emergency rooms, where the
patient is seen in episodes of disease exacerbation, since
this conditon is usually oligosymptomatic or asympto-
matic in early stages.
The patients, in addition to an adequate diagnosis, usually
require individualized health-care plans, as well as a pro-
longed follow-up of the disease. This care should be based
on a trained effective social and health-care team, that
includes health-care professionals and social services,
with the active participation of the patient's social net-
work [48,49].
Globally, the responsibilities of the general practitioner
(GP) regarding patients with syringomyelia and/or Chiari
syndrome are similar to those related to any patient with
low prevalent chronic diseases. Once diagnosed, the task
is to “accompany” the patient, attend to their needs and
associated problems, and assess any signs of worsening of
the condition [50].
Thus, two phases can be identified regarding the relation-
ship between the GP and the patient with syringomyelia
and/or Chiari syndrome: the pre-diagnostic phase and the
post-diagnostic phase.
The pre-diagnostic phase depends almost exclusively on
imaging studies, in this case, MRI. This fact makes the con-
dition practically undiagnosable in the primary care
clinic. Suspected patients have to be referred to a neurol-
ogy / neurosurgery clinic, where they can be assessed and
the presence or absence of the condition established.
Once the diagnosis is made, patients should be reassured
and, above all, informed that their symptoms are forms of
expression of a possible craniocervical junction malfor-
mation, which in many cases can be corrected surgically.
Also, control of the symptoms with the appropriate phar-
macological therapy is critical. Based mostly on analgesia,Page 8 of 11
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pain adequately.
Another professional closely linked to these patients after
diagnosis is the physiotherapist. The social worker also is
a key figure in the multidisciplinary approach to the care
of these patients in health centres. For the general practi-
tioner, referral of these patients to the social worker
should not just be a way of avoiding problems within the
patient's social environment, but a way to share the load
of care with these professionals.
Finally, in dependent patients it is necessary to develop
home care programmes, including the general practi-
tioner, nurse, physiotherapist, and social worker.
Although these patients comprise a small percentage of
the total number of people with this syndrome, it is in
these patients where primary care physicians must make
an extra effort to address their needs [51].
Role of the community
It is important to highlight the existence of advocacy
groups that form a network with, among other objectives,
the goal of disseminating health information to the com-
munity in order to increase the understanding, not only of
this condition, but of many others, through conferences,
seminars, or awareness campaigns at local and general
levels. The dissemination of information related to crani-
ocervical malformations from both health and social
standpoints fulfill the need, often demanded by commu-
nity members, for information on these diseases in partic-
ular, and on all Rare Diseases (RDs) in general.
Information is considered as the first step in training and
the keystone to any educational programme.
The educational programme referred above consists of
providing information and training to the professionals
involved in different aspects in the care of patients with
craniocervical malformations, fundamentally health-care
and social personnel (primary care doctors, specialists,
nurses, physiotherapists, speech therapists, psychologists,
social workers, etc.).
Legal issues
Advising a person with craniocervical malformations
regarding medical and legal issues can be very complex,
and should be undertaken by a qualified and experienced
specialist. The role of the medical professional is to pro-
vide up-to-date information, such as details of referrals
and recommendations for other professionals, investiga-
tions developed, and recommended therapies [20].
As mentioned before, this can be a disabling condition,
and may cause full disability in some patients, often
requiring legal support to claim economic aid, special
occupational conditions, occupational disability, and dis-
ability degree certification.
Work position adaptations, employment plans and pro-
motion, insertion in the workplace or reinsertion after a
prolonged sick leave, regardless of the worker's prepara-
tion and professional competence, are rights according to
the legislation in force, but only if the degree of disability
is 33% or more. Sometimes, this right is negotiated
through collective agreements, as a result of disease or per-
manent total disability.
Conclusions
It is important to determine the needs of the patients in
terms of health-care, social, educational, occupational,
and relationship issues, in addition to those derived from
information aspects, particularly at onset of symptoms.
It is critical and necessary for the patient to receive ade-
quate and validated information from the professionals
who will be caring for them, so it is necessary that health-
care professionals improve their communication skills
and provide information to the affected people.
Since craniocervical malformations occur with diverse
symptoms and an irregular course, these changing fea-
tures are the factors which complicate most the timely
diagnosis. Few primary care physicians are fully aware of
these diseases and are capable to establish the diagnosis.
It is necessary that professionals, especially primary care
physicians, learn to identify the most characteristic symp-
toms of the most frequent craniocervical malformations
(Chiari type I and syringomyelia) in order to develop a
diagnostic suspicion and refer appropriately patients for
diagnostic confirmation.
On the other hand, it is necessary that the physicians
involved in the care of people with this condition compre-
hensively approach the management and follow-up of the
patients, and that they organize interdisciplinary teams
including all the professionals that can help to increase
the quality of life of patients. In these teams, physiothera-
pists, rehabilitation medical specialists, pain specialists,
psychologists, etc. have a special role.
The usefulness of different complementary support thera-
pies should be verified, and should be included in the
portfolio of services of the public health system whenever
it is demonstrated that their use is beneficial for the
patient.
Finally, another aspect to highlight is the existing legisla-
tion and regulations that should be adapted to consider
these diseases as a possible cause of disability and dis-
capacity.Page 9 of 11
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